English
Home > Products > 15803-02-8

China 15803-02-8 Factory

We rely upon strategic thinking, constant modernisation in all segments, technological advances and of course upon our employees that directly participate inside our success for 15803-02-8,CAS NO 15803-02-8,4-Bromo-1-methylpyrazole, We goal at Ongoing system innovation, management innovation, elite innovation and sector innovation, give full play for the overall advantages, and constantly make improvements to support excellent.
15803-02-8, Welcome any of your inquiries and concerns for our products. We look forward to establishing a long-term business relationship with you in the near future. Contact us today. We are the first business partner to suit your needs!

Related Products

Hot Products

  • ecteinascidin 743

    ecteinascidin 743

    Product Name:ecteinascidin 743
    Molecular Formula:C39H43N3O11S
    Molecular Weight;761.84
    CAS Registry Number;114899-77-3
  • Flumequine sodium

    Flumequine sodium

    Product Name:Flumequine sodium
    Molecular Formula:C14H12FNNaO3*
    Molecular Weight;284.2381532
    CAS Registry Number;42835-68-7
  • 1-Methylcyclopropane-1-carboxylic acid

    1-Methylcyclopropane-1-carboxylic acid

    Product Name:1-Methylcyclopropane-1-carboxylic acid
    Molecular Formula:C5H8O2
    Molecular Weight:100.12
    CAS Registry Number:6914-76-7
  • Loxoprofen sodium

    Loxoprofen sodium

    Product Name:Loxoprofen sodium
    Molecular Formula:C15H19NaO3
    Molecular Weight;270.3
    CAS Registry Number;80382-23-6
  • 2-[2-(2-Fluorophenyl)-2-oxoethyl]propanedinitrile

    2-[2-(2-Fluorophenyl)-2-oxoethyl]propanedinitrile

    Product Name:2-[2-(2-Fluorophenyl)-2-oxoethyl]propanedinitrile
    Molecular Formula:C11H7FN2O
    Molecular Weight:202.18
    CAS Registry Number:312307-38-3
  • Lenalidomide

    Lenalidomide

    Product Name:Lenalidomide
    Molecular Formula:C13H13N3O3
    Molecular Weight;259.26
    CAS Registry Number;191732-72-6
  • Related Blog
  • Reviews

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

Related Search

CAS NO 15803-02-8

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept